Valganciclovir is used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people who have acquired immunodeficiency syndrome (AIDS). Valganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have received a heart, kidney, or kidney-pancreas transplant and who have a chance of getting CMV disease. Valganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV.
Valcyte Available Drugs :
Valcyte ndc# 0004-0038by Genentech, Inc.
ORAL TABLET, FILM COATED with active strength of 450 mg/1started marketing at 29/03/2001 .
Valcyte ndc# 0004-0039by Genentech, Inc.
ORAL POWDER, FOR SOLUTION with active strength of 50 mg/mLstarted marketing at 28/08/2009 .
Valcyte Search Trends: